Discover how CD58-negative leukemia initiating cells independently predict relapse risk in B-precursor acute lymphoblastic leukemia through comprehensive clinical and biological profiling.
Explore the revolutionary progress in molecular studies of Ph-positive and Ph-like acute lymphoblastic leukemia and how chemotherapy-free regimens are offering new hope.